ArticleFrontiers in pharmacology2026
Manuka honey as a natural remedy for diabetic foot ulcers: efficacy compared with silver-based dressing.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Diabetic foot ulcers (DFUs) present significant challenges in clinical management. Numerous studies have confirmed the effectiveness of honey in promoting the healing of cutaneous ulcers of various etiologies, including DFUs. The aim of the study is to compare the effectiveness of DFUs treatment with Manuka honey with the use of a classic silver-based dressing. Methods: A randomized controlled trial was conducted involving two groups of patients (a total of 60 individuals) with DFUs. Patients were randomly assigned to two groups: the experimental group received treatment with medical-grade Manuka honey, whereas the control group was treated with a silver-containing calcium alginate dressing. The investigated Manuka honey product was reported with full device identifiers to ensure clinical-grade product traceability. RESVECH 2.0 Scoring Table was used twice (just before procedure and after 4 weeks) to assess treatment effectiveness. It is a validated multidimensional scale designed to assess and monitor the progression of chronic wound healing across key clinical parameters. Results: With the exception of Depth/Tissues Involved, all evaluated parameters of RESVECH 2.0 Scoring Table demonstrated a significantly greater improvement in the experimental group compared with the control group (p < 0.001). Total score was reduced by 41.3% in the experimental group vs. 2.0% in the control group. Statistically significant, mostly positive correlations were found between wounding time and RESVECH 2.0 scores before and after 4 weeks of therapy, as well as between wounding time and the magnitude of treatment effect. Discussion: Manuka honey demonstrated greater efficacy than silver-based dressings in promoting the healing of diabetic foot ulcers, supporting its use as an effective alternative in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.